Prediction of adaptive strategies based on deformation vector field features for MR-guided adaptive radiotherapy of prostate cancer

被引:4
|
作者
Xia, Wen-Long [1 ]
Liang, Bin [1 ]
Men, Kuo [1 ]
Zhang, Ke [1 ]
Tian, Yuan [1 ]
Li, Ming-Hui [1 ]
Lu, Ning-Ning [1 ]
Li, Ye-Xiong [1 ,2 ]
Dai, Jian-Rong [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union MedicalCollege, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Radiat Oncol, Beijing 100021, Peoples R China
基金
中国国家自然科学基金;
关键词
adaptive strategy; deformation vector field; machine learning; MR-guided adaptive radiotherapy; IMAGE REGISTRATION; RADIATION-THERAPY; ALGORITHMS; SYSTEM;
D O I
10.1002/mp.16192
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundThe selection of adaptive strategies in MR-guided adaptive radiotherapy (MRgART) usually relies on subjective review of anatomical changes. However, this kind of review may lead to improper selection of adaptive strategy for some fractions. PurposeThe purpose of this study was to develop prediction models based on deformation vector field (DVF) features for automatic and accurate strategy selection, using prostate cancer as an example. Methods100 fractions of 20 prostate cancer patients were retrospectively selected in this study. Treatment plans using both adapt to position (ATP) strategy and adapt to shape (ATS) strategy were generated. Optimal adaptive strategy was determined according to dosimetric evaluation. DVFs of the deformable image registration (DIR) of daily MRI and CT simulation scans were extracted. The shape, first order statistics, and spatial features were extracted from the DVFs, subjected to further selection using the minimum redundancy maximum relevance (mRMR) method. The number of features (F-n) was hyper-tuned using bootstrapping method, and then F-n indicating a peak area under the curve (AUC) value was used to construct three prediction models. ResultsAccording to subjective review, the ATS strategy was adopted for all 100 fractions. However, the evaluation results showed that the ATP strategy could have met the clinical requirements for 23 (23%) fractions. The three prediction models showed high prediction performance, with the best performing model achieving an AUC value of 0.896, corresponding accuracy (ACC), sensitivity (SEN) and specificity (SPC) of 0.9, 0.958, and 0.667, respectively. The features used to construct prediction models included four features extracted from y direction of DVF (DVFy) and mask, one feature from z direction of DVF (DVFz). It indicated that the deformation along the anterior-posterior direction had a greater impact on determining the adaptive strategy than other directions. ConclusionsDVF-feature-based models could accurately predict the adaptive strategy and avoid unnecessary selection of time-consuming ATS strategy, which consequently improves the efficiency of the MRgART process.
引用
收藏
页码:3573 / 3583
页数:11
相关论文
共 50 条
  • [21] Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Prostate Cancer
    Lagerwaard, F.
    Bruynzeel, A.
    Tetar, S.
    Oei, S. S.
    Haasbeek, C.
    Slotman, B. J.
    Senan, S.
    Bohoudi, O.
    Palacios, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E681 - E682
  • [22] The impact of rectal spacers in MR-guided adaptive radiotherapy
    Batumalai, Vikneswary
    Crawford, David
    Picton, Maddison
    Tran, Charles
    Jelen, Urszula
    Carr, Madeline
    Jameson, Michael
    de Leon, Jeremy
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 49
  • [23] Deformable Dose Accumulation and Toxicity Analysis in Prostate Cancer Patients Undergoing MR-Guided Adaptive Radiotherapy
    Rezaeian, N. Hassan
    Gui, C.
    Bosma, L.
    Sudharsan, M.
    Burleson, S.
    Cote, N.
    Brennan, V. S.
    Tyagi, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E136 - E136
  • [24] Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy
    Christiansen, R. L.
    Dysager, L.
    Hansen, C. R.
    Schytte, T.
    Bertelsen, A. S.
    Jensen, H. R.
    Mahmood, F.
    Nyborg, C. J.
    Hansen, S.
    Agergaard, S. N.
    Hansen, O.
    Brink, C.
    Bernchou, U.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1488 - S1489
  • [25] MR-guided adaptive SBRT for prostate cancer: stability of adaptive planning analyzed by repetitive imaging
    Heitmann, Jana
    Heitmann, J.
    Chamberlain, M.
    Baumgartl, M.
    Krayenbuhl, J.
    Zamburlini, M.
    Mayinger, M.
    Wilke, L.
    Andratschke, N.
    Tanadini-Lang, S.
    Guckenberger, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1149 - 1150
  • [26] Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy
    Sandoval, Maria L.
    Rishi, Anupam
    Latifi, Kujtim
    Grass, G. Daniel
    Torres-Roca, Javier
    Rosenberg, Stephen A.
    Yamoah, Kosj
    Johnstone, Peter A. S.
    CANCER CONTROL, 2024, 31
  • [27] Preliminary experience using MR-guided adaptive radiotherapy in head and neck cancer
    Atienza, Caiden
    Shepard, Andrew
    Uzomah, Uwajachukwumma
    Rajan, Shri Kiriti
    Anderson, Carryn M.
    Katzer, Joel
    Rusu, Samuel
    St-Aubin, Joel
    Smith, Blake
    Hyer, Daniel
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
    Tetar, Shyama U.
    Bohoudi, Omar
    Senan, Suresh
    Palacios, Miguel A.
    Oei, Swie S.
    van der Wel, Antoinet M.
    Slotman, Berend J.
    van Moorselaar, R. Jeroen A.
    Lagerwaard, Frank J.
    Bruynzeel, Anna M. E.
    CANCERS, 2020, 12 (10) : 1 - 11
  • [29] Feasibility and first experience of MR-guided adaptive radiotherapy for head and neck cancer
    Balermpas, P.
    Krayenbuhl, J.
    Chamberlain, M.
    Bogowicz, M.
    Garcia-Schuler, H. I.
    Andratschke, N.
    Moreira, A. K.
    Wilke, L.
    Tanadini-Lang, S.
    Guckenberger, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S443 - S443
  • [30] Stereotactic radiotherapy and MR-guided adaptive techniques for locally advanced pancreatic cancer
    Ermongkonchai, T.
    Khor, R.
    Muralidharan, V.
    Tebbutt, N.
    Lim, K.
    Kutaiba, N.
    Ng, S. P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1001 - S1002